Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency

Summary

The researchers propose the use of mifepristone as an alternative way to test for Central Adrenal Insufficiency (CAI). They want to assess the feasibility of recruitment and the efficacy of the purposed method.

Timeline

Start

2021-05-05

Primary completion

2021-08-01

Completion

2021-08-01

Outcome

Outcome not reported

Stopped (Enrollment): “low recruitment”

Drugs

Indications